Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Genital psoriasis affects 33-63% patients with psoriasis during the course of disease, usually leading to a severe reduction of patient’s quality of life. This study aims to retrospectively asses the effectiveness of interleukin (IL)-23 and IL-17 inhibitors in a real-life population affected by mod...

Full description

Bibliographic Details
Main Authors: Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
Format: Article
Language:English
Published: PAGEPress Publications 2023-05-01
Series:Dermatology Reports
Subjects:
biologics
genital psoriasis
psoriasis treatment
Online Access:https://www.pagepress.org/journals/index.php/dr/article/view/9692

Similar Items

Similar Items